Cytonect is a biotechnology company developing topical therapeutics that calm inflammation at the cellular level — beginning with a next-generation anti-inflammatory pomade for skin, with a growing pipeline of bioactive technologies.
Inflammation sits at the root of many of the most common and stubborn skin concerns. Most products address the symptoms — the redness, the irritation — without touching what causes them.
Cytonect was founded to work a layer deeper. By designing around the cellular signaling that drives inflammation, we aim to calm skin at its source while supporting its natural barrier.
Our lead technology is a topical anti-inflammatory pomade. It is the first of several bioactive technologies we're developing — and the beginning of a longer body of work.
To translate cellular science into topical therapeutics that genuinely improve skin health.
Address the cause, not the surface. Support the barrier. Build products people can actually use.
We hold our work to the standard of real science — measured, tested, and honest about what we know.
We solve a specific problem well before we broaden. Inflammation in skin is where we start.
Good products take time. We build toward something durable rather than rushing to a shelf.